Similar Items: Consistency of response to rimegepant for the acute treatment of migraine among real-world users – findings from the prospective observational CONFIDENCE study
- Real-world effectiveness and safety of CGRP monoclonal antibodies in elderly migraine patients: a Korean multicenter study
- CGRP-targeted migraine treatment and early pathophysiology in experimental subarachnoid hemorrhage
- Is migraine a spectrum disorder? Questioning the concept of “episodic” and “chronic” migraine using population-based data from 10,226 adults with migraine from 14 countries
- Clinical and social burden of migraine in Japanese males: a cross-sectional comparison with females without menstrual migraine
- Source-level α periodic power in visual and default mode networks predicts topiramate treatment response in migraine
- Mapping structural and functional brain networks associated with migraine